Detalhe da pesquisa
1.
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions.
J Urol
; 211(4): 526-532, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421252
2.
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy.
J Urol
; 211(4): 509-517, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421253
3.
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy.
J Urol
; 211(4): 518-525, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421243
4.
Racial inequities in the quality of surgical care among Medicare beneficiaries with localized prostate cancer.
Cancer
; 129(9): 1402-1410, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36776124
5.
DNA methylation and cis-regulation of gene expression by prostate cancer risk SNPs.
PLoS Genet
; 16(3): e1008667, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32226005
6.
A Patient-Centered Approach to Research Prioritization in Prostate Cancer.
J Urol
; 208(2): 277-283, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35394343
7.
Does Clinical Evidence of Heterogeneity Impact Treatment Selection? A Case Study of Abiraterone for Metastatic Prostate Cancer.
J Natl Compr Canc Netw
; 20(10): 1107-1115.e12, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240855
8.
Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8-10) prostate cancer treated primarily by radical prostatectomy.
Cancer
; 127(9): 1425-1431, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33721334
9.
Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer.
J Urol
; 204(4): 748-753, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32259468
10.
African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study.
J Urol
; 203(4): 727-733, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31651227
11.
Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centers.
Cancer
; 125(3): 391-397, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30423193
12.
Does time from diagnosis to treatment of high- or very-high-risk prostate cancer affect outcome?
BJU Int
; 124(2): 282-289, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30653804
13.
Reconsidering the Trade-offs of Prostate Cancer Screening. Reply.
N Engl J Med
; 383(13): 1290, 2020 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32966736
14.
Reconsidering the Trade-offs of Prostate Cancer Screening.
N Engl J Med
; 382(25): 2465-2468, 2020 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32558473
15.
Genomic Scores are Independent of Disease Volume in Men with Favorable Risk Prostate Cancer: Implications for Choosing Men for Active Surveillance.
J Urol
; 199(2): 438-444, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28941920
16.
Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable Features.
J Urol
; 199(2): 445-452, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28789947
17.
18.
Translating Patient-Centered Research into Educational Resources to Address Racial Inequities in Prostate Cancer.
J Urol
; 207(3): 496-497, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34967664
19.
Do Renin-Angiotensin Blockers Affect Renal Function and Cardiac Outcomes in Patients Undergoing Partial Nephrectomy?
J Urol
; 197(3 Pt 1): 566-573, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27746281
20.
Intermediate-Term Outcomes for Men with Very Low/Low and Intermediate/High Risk Prostate Cancer Managed by Active Surveillance.
J Urol
; 198(3): 591-599, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28347770